Veterinary Medicines

Benestermycin vet. Intramammär salva

Authorised
  • Penethamate hydriodide
  • Framycetin sulfate
  • Benethamine penicillin
Download as PDF

Product identification

Medicine name:
Benestermycin vet. Intramammär salva
Active substance:
  • Penethamate hydriodide
  • Framycetin sulfate
  • Benethamine penicillin
Target species:
  • Cattle
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Penethamate hydriodide
    100.00
    milligram(s)
    /
    1.00
    Syringe
  • Framycetin sulfate
    100.00
    milligram(s)
    /
    1.00
    Syringe
  • Benethamine penicillin
    280.00
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary ointment
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle
      • Milk
        37
        day
      • Meat and offal
        9
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RC25
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Sweden
Available in:
  • Sweden
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Haupt Pharma Latina S.r.l.
  • Lohmann Pharma Herstellung GmbH
Responsible authority:
  • Swedish Medical Products Agency
Authorisation number:
  • 8804
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 20/04/2023
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 26/04/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."